Monday, October 26, 2026 · Daily editionET --:--:--

Status not kept up to date

Virtual 3D Modelling for Improved Surgical Planning of Robotic-assisted Partial Nephrectomy

NCT05109182 · Innersight Labs Ltd · Updated 5 Nov 2021

What is being tested
Innersight3D
For
Kidney Cancer
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 80 years. About 328 people. The full rules are on the registry page.
Where
Not stated
When
Starts or started 1 Jan 2022, ends 1 Aug 2023. Registered 5 Nov 2021.
Results
None posted yet.

In the researchers' words

To establish whether surgical planning using virtual 3D modelling (Innersight 3D) improves the outcome and cost-effectiveness of RAPN, allowing more patients to benefit from minimally-invasive procedures.
ClinicalTrials.gov, NCT05109182